Cannasouth + Eqalis Merger
On 1 June 2023 Cannasouth merged with leading medicinal cannabis company Eqalis.
Together we will deliver better outcomes for patients – both locally and globally – by combining IP, technology, research and development, innovation, manufacturing, sales, and prescribing capabilities.
The Cannasouth Group now operates end-to-end with GMP approval for producing dried cannabis flower and manufacturing cannabis-based ingredients and medicinal cannabis products, including oral solutions.
This page contains all information available about the merger.